
Ribomic
4591.TRibomic Inc. Price (4591.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
35,691,593
(14.7296)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. Ribomic Inc. was incorporated in 2003 and is headquartered in Tokyo, Japan. Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $60-136
- Market Cap 5.22B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Mr. Yoshikazu Nakamura Ph.D.
- IPO Date: September, 25, 2014
- Country: JP
- Currency: JPY
- Headquaters: No Data
- Employees: 24
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
